Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Fund of Funds
  • Objective: Aggressive Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Global

Cleome Index - Global Equities

+ Add to Watchlist

CLEIGEC:LX

146.47 EUR 0.50 0.34%

As of 00:59:30 ET on 05/20/2015.

Snapshot for Cleome Index - Global Equities (CLEIGEC)

Year To Date: +18.03% 3-Month: +6.38% 3-Year: +20.68% 52-Week Range: 114.58 - 152.66
1-Month: -0.58% 1-Year: +25.83% 5-Year: - Beta vs LUXXX: 0.77

Mutual Fund Chart for CLEIGEC

No chart data available.
  • CLEIGEC:LX 146.47
  • 1M
  • 1Y
Interactive CLEIGEC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CLEIGEC

Cleome Index Global Equities is a SICAV incorporated in Luxembourg. The Fund's objective is to replicate the performance of the composite index: MSCI Europe (65%), MSCI World Ex-Europe (25%), MSCI Emerging Markets (10%). The Fund will invest mainly in equities but can also invest in other OPCVMs and derivatives.

Inception Date: 03-25-2011 Telephone: 352-254-3431
Managers: IVO DE BONDT
Web Site: www.candriam.com

Fundamentals for CLEIGEC

NAV (on 2015-05-20) 146.47
Assets (M) (on 2015-05-20) 247.39
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for CLEIGEC

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2015-04-28) 3.00
Dividend Yield (ttm) 2.05

Fees & Expenses for CLEIGEC

Front Load 2.50
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLEIGEC

Filing Date: 03/31/2015
Name Position Value % of Total
Candriam Equities L Emerging M 28,268 23,714,025 9.908%
Nestle SA 60,098 4,228,617 1.767%
Novartis AG 44,846 4,133,475 1.727%
Roche Holding AG 13,855 3,560,784 1.488%
HSBC Holdings PLC 344,439 2,732,751 1.142%
Bayer AG 16,840 2,356,758 0.985%
Sanofi 23,752 2,183,521 0.912%
BP PLC 351,356 2,120,833 0.886%
Novo Nordisk A/S 41,764 2,079,610 0.869%
GlaxoSmithKline PLC 97,052 2,073,910 0.867%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil